In addition, several clinical studies have shown that activation of NLRP3 is associated with systemic or local inflammation in RA, and in vivo studies have also shown enhanced expression of NLRP3 inflammasome components in macrophages and that NLRP3 deficiency suppresses the development of arthritis and cartilage destruction. Here, NLRP3 is linked to rheumatoid arthritis.